SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 5, 2008 (October 30, 2008)
GUIDED THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware (State or Other Jurisdiction of Incorporation) |
0-22179 (Commission File Number) |
58-2029543 (IRS Employer Identification No.) |
4955
Avalon Ridge Pkwy, Suite 300 |
30071 |
Registrant's Telephone Number, Including Area Code: (770) 242-8723
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. REGULATION FD DISCLOSURE. |
Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS. |
SIGNATURES |
EXHIBIT INDEX |
EXHIBIT 99.1 Press release, dated October 30, 2008 |
Item 7.01. Regulation FD Disclosure.
On October 30, 2008, Guided Therapeutics, Inc. ("GT") and Konica Minolta Opto, Inc. of Tokyo announced that the two companies extended an option to license and no shop agreement to co-develop certain of GT's non-invasive technologies , as more fully described in the press release, a copy of which is furnished as Exhibit 99.1 hereto, which information is incorporated herein by reference.Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit No. | Exhibit Description | |
99.1 | Press Release, dated October 30, 2008 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GUIDED THERAPEUTICS, INC. | ||||
/s/ MARK L. FAUPEL |
||||
By: | Mark L. Faupel, Ph.D. | |||
President & CEO | ||||
Date: November 5, 2008. |
EXHIBIT INDEX
Exhibit No. | Exhibit Description | |
99.1 | Press Release, dated October 30, 2008 |